Total Payments
$1,608
2024 Payments
$18.44
Companies
10
Transactions
37
Medicare Patients
1,726
Medicare Billing
$156,735
Payment Breakdown by Category
Food & Beverage$1,473 (91.6%)
Other$100.00 (6.2%)
Education$34.93 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,473 | 33 | 91.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100.00 | 1 | 6.2% |
| Education | $34.93 | 3 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $412.16 | 4 | $0 (2020) |
| GlaxoSmithKline, LLC. | $387.35 | 13 | $0 (2018) |
| Novo Nordisk Inc | $243.52 | 9 | $0 (2020) |
| Amgen Inc. | $211.92 | 2 | $0 (2020) |
| Astellas Pharma US Inc | $125.00 | 1 | $0 (2017) |
| Lilly USA, LLC | $123.42 | 2 | $0 (2018) |
| EMD Serono, Inc. | $35.90 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.82 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $18.44 | 1 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $17.45 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.44 | 1 | Novartis Pharmaceuticals Corporation ($18.44) |
| 2020 | $232.84 | 5 | Indivior Inc. ($99.77) |
| 2019 | $311.49 | 6 | Novo Nordisk Inc ($186.49) |
| 2018 | $502.75 | 14 | GlaxoSmithKline, LLC. ($246.47) |
| 2017 | $542.46 | 11 | GlaxoSmithKline, LLC. ($140.88) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Diabetes | ||||||
| 07/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $99.77 | General |
| Category: OUD | ||||||
| 01/23/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $89.09 | General |
| Category: Cardiology | ||||||
| 01/08/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Diabetes | ||||||
| 10/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $120.75 | General |
| Category: Diabetes | ||||||
| 10/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes | ||||||
| 09/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Diabetes | ||||||
| 06/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Diabetes | ||||||
| 04/17/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Diabetes | ||||||
| 03/26/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OUD | ||||||
| 12/19/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Neuroscience | ||||||
| 10/03/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $86.29 | General |
| Category: VACCINES | ||||||
| 09/20/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Cardiology | ||||||
| 09/12/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2018 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $87.39 | General |
| Category: OUD | ||||||
| 08/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $123.82 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: RESPIRATORY | ||||||
| 01/16/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 348 | 499 | $95,498 | $31,706 |
| 2022 | 8 | 321 | 440 | $93,935 | $29,045 |
| 2021 | 10 | 360 | 451 | $130,045 | $37,706 |
| 2020 | 13 | 697 | 891 | $206,232 | $58,278 |
Total Patients
1,726
Total Services
2,281
Medicare Billing
$156,735
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 136 | $27,311 | $8,791 | 32.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 82 | 89 | $22,735 | $8,227 | 36.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 93 | 191 | $25,830 | $7,923 | 30.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 39 | 40 | $7,125 | $2,592 | 36.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $7,322 | $2,311 | 31.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 21 | $5,175 | $1,862 | 36.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 100 | 184 | $33,360 | $10,624 | 31.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 74 | 78 | $21,510 | $6,617 | 30.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 40 | 54 | $14,445 | $4,379 | 30.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $6,955 | $2,060 | 29.6% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,245 | $1,411 | 33.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 23 | 23 | $3,910 | $1,400 | 35.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 26 | 26 | $4,940 | $1,341 | 27.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 26 | 43 | $4,570 | $1,212 | 26.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 73 | 76 | $23,180 | $6,867 | 29.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 24 | 36 | $22,680 | $6,772 | 29.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 73 | 101 | $20,705 | $6,007 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 53 | $15,635 | $4,688 | 30.0% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 35 | 35 | $13,475 | $4,419 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 47 | $9,870 | $2,694 | 27.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 25 | 25 | $9,750 | $2,628 | 27.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 28 | 28 | $5,880 | $1,678 | 28.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 23 | 34 | $3,910 | $1,031 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 16 | $4,960 | $922.65 | 18.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 144 | 272 | $79,424 | $20,682 | 26.0% |
About Dr. Michael Keenan, M.D
Dr. Michael Keenan, M.D is a Internal Medicine healthcare provider based in Coventry, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760430102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Keenan, M.D has received a total of $1,608 in payments from pharmaceutical and medical device companies, with $18.44 received in 2024. These payments were reported across 37 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,473).
As a Medicare-enrolled provider, Keenan has provided services to 1,726 Medicare beneficiaries, totaling 2,281 services with total Medicare billing of $156,735. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Coventry, CT
- Active Since 05/05/2006
- Last Updated 08/16/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760430102
Products in Payments
- SUBLOCADE (Drug) $312.16
- Ozempic (Drug) $230.47
- Repatha (Biological) $211.92
- ANORO (Drug) $153.03
- Myrbetriq (Drug) $125.00
- ANORO ELLIPTA (Drug) $122.60
- TRULICITY (Drug) $110.18
- SUBOXONE SUBLINGUAL FILM (Drug) $100.00
- BEXSERO (Biological) $86.29
- SEROSTIM (Biological) $35.90
- SPIRIVA RESPIMAT (Drug) $18.93
- ENTRESTO (Drug) $18.44
- LATUDA (Drug) $17.45
- STIOLTO RESPIMAT (Drug) $13.89
- EMGALITY (Drug) $13.24
- Victoza (Drug) $13.05
- SHINGRIX (Biological) $10.52
- BREO (Drug) $4.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Coventry
Sergio Rodriguez Serrano, M.d, M.D
Internal Medicine — Payments: $289.56
Internal Medicine $289.56
Timothy Manown, M.d, M.D
Internal Medicine — Payments: $106.51
Internal Medicine $106.51
Robert Hance, Md, MD
Internal Medicine — Payments: $53.18
Internal Medicine $53.18
Dr. Donald Hebb, Md, MD
Internal Medicine — Payments: $40.43
Internal Medicine $40.43
Matthew Hall, Do, DO
Internal Medicine — Payments: $15.59
Internal Medicine $15.59